NeurogesX (NGSX)
NeurogesX News
NEUROGESX INC Files SEC form 10-Q, Quarterly Report
about 20 days agoNEUROGESX INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra
about 26 days agoNEUROGESX INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements a
about 27 days agoNeurogesX Reports First Quarter 2012 Results
GlobeNewswire about 27 days agoQ1 2012 and Recent Highlights:
Robbins Umeda LLP Announces an Investigation of NeurogesX, Inc.
Business Wire about 27 days agoShareholder rights firm Robbins Umeda LLP is investigating possible breaches of fiduciary duty and other violations of the law by certain officers and directors at NeurogesX, Inc. .
NEUROGESX INC Files SEC form 8-K, Other Events
about 33 days agoNeurogesX to Hold Conference Call to Discuss First Quarter 2012 Results
GlobeNewswire about 34 days agoSAN MATEO, Calif. -- NeurogesX, Inc. , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced it will hold ...
The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in NeurogesX, Inc. of Class Action Lawsuit
PR Newswire about 37 days agoNEW YORK, April 23, 2012 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of ...
Stocks to Watch: Wal-Mart, Kellogg, ConocoPhillips
about 38 days agoNEUROGESX INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra
about 40 days agoNeurogesX Receives Determination Letter From NASDAQ; Not Regaining Compliance
Benzinga about 40 days agoNeurogesX Receives Determination Letter From NASDAQ
GlobeNewswire about 40 days agoSAN MATEO, Calif. -- NeurogesX, Inc. , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced that it received ...
UPDATE 1-NeurogesX seeks partners for pain drugs
about 44 days agoNeurogesX (NGSX) Taps Advisor in Evaluating Development Objectives
Street Insider about 44 days agoYou may also be interested in these NGSX related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NGSX | 0.35 | -0.02 | -5.41% | 11.07M |
| NGB | 16.30 | -0.25 | -1.51% | |
| NG | 5.91 | +0.15 | +2.60% | 1.601B |
| NFZ | 14.65 | -0.02 | -0.14% | |
| NE | 32.61 | -1.54 | -4.51% | 8.612B |
| NDX | 2559 | +31.92 | +1.26% | |
| NDSN | 53.62 | -0.48 | -0.89% | 3.527B |
| NDAQ | 21.82 | -0.40 | -1.80% | 3.853B |
| NCZ | 7.89 | -0.20 | -2.47% | |
| NCV | 8.73 | -0.16 | -1.80% |
